The FARADIGM global IDE clinical trial is now underway.
Designed to evaluate the FARAFLEX™ Mapping and Pulsed Field Ablation Catheter with the OPAL HDx™ Mapping System, the FARADIGM study is an important next step in building evidence for a large focal, map-and-ablate PFA approach.
This pivotal trial reflects our shared commitment to drive continuous innovation, advance clinical insights and relentlessly pursue better outcomes across a broader range of AF patients.
We’re grateful to Andrea Natale, M.D., and the Texas Cardiac Arrhythmia Research team at St. David’s Medical Center for performing the first procedures and helping advance the evidence base for the EP community.
See the latest FARAFLEX data:
https://t.co/0ariKlTyCS
FARAFLEX™ Mapping and Pulsed Field Ablation Catheter – CAUTION: Investigational Device. Limited by Federal (or US) law to investigational use only. Not available for sale.
FARAPULSE™ Pulsed Field Ablation System Indications, Safety, and Warnings: https://t.co/A64fZE9GVn
OPAL HDx™ Mapping System Indications, Safety, and Warnings: https://t.co/wu777PHkBb
First cases of #FARAPOINT in LMR at ULS Santo António!
CTI ablation after isolation of the veins in 2min in the fifth application.
Final test blockade in the CTI with a delay of 190ms.
A new generation of catheter designed to expand the #farapulse platform and allow the treatment of other types of arrhythmias safely, quickly and successfully.
@APinheiroVieira@Claudiojh89 Diana Ribeiro
Andre Luz Sonia Magalhaes Maria João Sousa @andrefalexandre Odete Ramires Sandra Santos Mariana Rajão @BSC_EU_Heart@BSCCardiology@bostonsci
#ep #cti #pfa #farapulse #farapoint #flutter #fa #cardiology #bsci #boston #bostonscientific
Prof. Ignacio García Bolao, Prof. Serge Boveda and Prof. Gábor Széplaki discuss how they approach posterior wall isolation (#PWI) in clinical practice and when they choose to perform it.
Watch the full discussion: https://t.co/qHqkGPJjlb
#Epeeps#PFA#Afib#MedEd
Case number fifty at Hospital Lusíadas Saúde Porto with #FARAPULSE. 🌸
A new reality in the innovation of Atrial Fibrillation treatment. 🫀
António Pinheiro Vieira
Ana Margarida Gomes Lebreiro
Cláudio Henriques
André Alexandre
Lusíadas Saúde
Lusíadas Knowledge Center
Boston Scientific
Boston Scientific Cardiology
#PFA #FARAPULSE #BSCI #BostonScientific #Cardiology #EP #atrialfibrillation #AF
🎭 My caricature made by AI 😂
👨⚕️ The Maestro of Cardiac Rhythms
In the morning he’s in a lab coat, staring at a 3D map of the left atrium like someone analyzing a Renaissance masterpiece.
He doesn’t perform ablations — he performs precision myocardial sculpture.
While others say:
— “He has an arrhythmia.”
You say:
— “Interesting… seems like an accessory pathway with its own personality.”
The FARAWAVE isn’t a catheter.
It’s basically a cardiology lightsaber.
⸻
📊 The Strategic Investor
Between ablations, he opens his phone:
Boston Scientific?
Ryanair?
Crypto?
Lisbon Stock Exchange?
You don’t check the market.
You interrogate the market.
If Wall Street had electrophysiology, it would have already hired you to map support and resistance zones.
⸻
🎾 The Padel Scientist
On the padel court, no one is just playing against you.
They’re being studied.
Your opponent thinks he just missed an easy shot.
But in reality, he just participated in a clinical trial on decision-making under pressure.
Racket choice, weight, foam hardness, ball output —
none of it is equipment.
It’s physiology applied to social competition.
⸻
🏋️ The Disciplined Pump Enthusiast
Five months with a personal trainer and you already talk about “consistency” like it’s a clinical endpoint.
Training isn’t training — it’s a randomized phase III protocol.
If someone misses a set, you want to know:
— “What was the pathophysiological mechanism behind the performance drop?”
⸻
🌍 The Visionary
Amid all of this, you’re still conceptualizing a new electrophysiology lab — modern architecture, cutting-edge technology.
Because if you’re going to treat arrhythmias…
You treat them with style.
2025!
Wow, what a year, very hard, very heavy, but so rewarding! 🙏💫
My many thanks to everyone who trusted my/our work, professionalism, care, experience and dedication. 💙
It was a year of new therapies, new centers, many more patients treated. 💪🏼
There were many cases of #OPAL, many cases of #FARAPULSE, many cases of #FARAVIEW, concomitant cases #FARAPULSE and #WATCHMAN, all with a single goal to bring the best to the patient, to offer the best treatment.
My THANK YOU VERY MUCH! 🙏💙
#bostonscientific #bsci #emea #ep #cardiology
@BSCCardiology@BSC_EU_Heart
Combining the familiar VersaCross™ RF Wire with a high-precision steerable sheath, the 8.5F VersaCross™ Steerable Access Solution provides smooth, bidirectional steering, allowing for controlled and targeted delivery of left heart therapies. See full benefits: https://t.co/ICMkgubsYG
VersaCross™ Steerable Access Solution Indications, Safety, and Warnings: https://t.co/8j4j4dilnw
#EPeeps
COMING SOON: The FARAPULSE™ PFA Platform will be expanding to include the FARAPOINT™ Pulsed Field Ablation (PFA) Catheter, upon FDA approval, a NAV-enabled PFA optimized catheter designed to create both focal and linear-shaped lesions. Prepare to enhance your #PFA workflow with FARAPOINT™.
See how it works: https://t.co/Vk9DKU2E4V
#EPeeps #PulsedFieldAblation
NEW MANIFEST-US REAL-WORLD REGISTRY DATA presented at #AHA2025 reinforces the consistent safety and performance of FARAPULSE™ #PFA as demonstrated across over 70,000 patients in 8 real-world studies.
MANIFEST-US data highlights:
• ZERO esophageal fistulas
• ZERO PV stenosis
• ZERO persistent phrenic nerve palsy
• 0.63% major adverse event rate
See the data: https://t.co/QlBqfBfFkk
FARAPULSE™ Pulsed Field Ablation System Indications, Safety, and Warnings: https://t.co/A64fZE9GVn
#EPeeps
🫀The Farapulse PFA ADVANCED Academy at @Hospital12deOct brought together experienced European physicians for live cases, peer learning & insights beyond the fundamentals of PFA.
Thanks to the @Cardio_H12O, faculty & participants.
💡More advanced formats coming in 2026
Boston Scientific is partnering with @SiemensHealth on the workflow development and commercialization of a next-generation ACUNAV 4D ICE catheter designed to enable guidance from the right atrium, streamline workflows and simplify procedures.
The technology is intended to offer physicians an innovative imaging option for standalone WATCHMAN™ #LAAC Device procedures, FARAWATCH™ concomitant procedures utilizing the WATCHMAN LAAC Device and FARAPULSE™ #PFA Platform, as well as other structural heart procedures.
OPTIMIZE has begun! This trial pairs the Cortex OPTIMAP™ Electrographic Flow (EGF) Mapping Technology with the FARAPULSE™ PFA Platform to explore a more personalized approach to AF treatment—evaluating how EGF-guided mapping and #PFA ablation of AF sources may improve outcomes for patients with persistent AF.
Congrats to Dr. @omwazni, Global Principal Investigator, on completing the first case!
Learn more: https://t.co/G5JMSdw9Xn